Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1861123 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $9.49Day −3.95%Mkt cap $514MOff 52W high −45.5%Vol (1Y) 96.9%
Daily closing price, split-adjusted to the current basis; 0.4y shown of 109 bars on file. Sampled to 109 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.5% of sh out |
| Days to cover11.5d |
| Top-10 13F concentration73.4% |
| Next report (est.)2026-08-03 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
No standardized fundamentals available.
No return windows available for EIKN.
| Ann. volatility (1Y)96.9% |
| Ann. volatility (3Y)96.9% |
| Sharpe (1Y)−0.62 |
| Sharpe (3Y)−0.62 |
| Max drawdown (1Y)−48.6% |
| Max drawdown (3Y)−48.6% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 3.8M | $41M | 7.09% | new |
| BlackRock, Inc. | 3.3M | $35M | 6.13% | new |
| Foresite Capital Management IV, LLC | 1.9M | $21M | 3.59% | new |
| Merck & Co., Inc. | 1.7M | $18M | 3.08% | new |
| Foresite Capital Management V, LLC | 1.3M | $14M | 2.44% | new |
| T. Rowe Price Investment Management, Inc. | 1.2M | $13M | 2.26% | new |
| Capital World Investors | 1.1M | $12M | 2.11% | new |
| ALLIANCEBERNSTEIN L.P. | 1.0M | $11M | 1.89% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for EIKN.
